Novo Nordisk: Is there life after slow death for slimmed down drug maker?Proactive Investors • 08/06/25
Novo Nordisk's sales increased by 16% in Danish kroner and by 18% at constant exchange rates to DKK 154.9 billion in the first six months of 2025GlobeNewsWire • 08/06/25
Investor Alert: Robbins LLP Informs Investors of the Novo Nordisk A/S Class Action LawsuitGlobeNewsWire • 08/06/25
Novo Nordisk A/S Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 30, 2025 to Discuss Your Rights – NVOGlobeNewsWire • 08/05/25
Berger Montague PC Announces Class Action Filed Against Novo Nordisk A/S (NYSE: NVO) for Alleged Securities ViolationsPRNewsWire • 08/05/25
Rosen Law Firm Urges Novo Nordisk A/S (NYSE: NVO) Investors with Losses in Excess of $100K to Contact the Firm for Information About Their RightsBusiness Wire • 08/05/25
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVOGlobeNewsWire • 08/05/25
GLP-1 War: A Look At The Epic Pipeline Battle Between Novo Nordisk And Eli LillySeeking Alpha • 08/05/25
Nordisk to downgraded by leading investment bank as growth slows and competition intensifiesProactive Investors • 08/05/25
Lost Money on Novo Nordisk A/S(NVO)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskyPRNewsWire • 08/05/25
Novo Nordisk is no longer a buy at UBS, which says compounding is here to stayMarket Watch • 08/05/25